The latest thoracic oncology news
Novel AI blood testing technology can ID lung cancers with high accuracy
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel…
The latest thoracic oncology news
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel…
In 2018, lung cancer caused 1.8 million cancer deaths worldwide. It is the most common…
Immunotherapy agents that inhibit the molecules PD1, PD-L1 or CTLA-4 have become widely used in…
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel…
Immunotherapy has become an important tool in the treatment of lung cancer, especially checkpoint inhibitors that…
The Thoracic Oncology Group of Australasia (TOGA) was established in 2020 as the lead independent…
Lung cancer is the leading cause of cancer death among men and women in the…
KRAS was one of the first oncogenes to be identified, a few decades ago. It…
A prospective cohort study found that quitting smoking after being diagnosed with early-stage non-small cell…
A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the…